Subscribe to RSS
DOI: 10.1055/s-2008-1027586
© Georg Thieme Verlag KG Stuttgart · New York
Azathioprin in der Kinder- und Jugendrheumatologie
Azathioprine in Paediatric and Adolescent RheumatologyPublication History
Publication Date:
21 July 2008 (online)

Zusammenfassung
In der Kinder- und Jugendrheumatologie bestehen Erfahrungen mit Azathioprin seit Ende der 1960er-Jahre. Bei Kindern und Jugendlichen ist es bei mäßiger Datenlage bei chronisch-entzündlichen Darmerkrankungen, bei systemischem Lupus erythematodes, bei Dermatomyositis, bei Polyarteriitis nodosa, beim Morbus Behçet und bei der Autoimmunhepatitis einsetzbar. Bei juveniler idiopathischer Arthritis gilt es bei ebenfalls mäßiger Datenlage als Reservemedikament.
Abstract
Azathioprine has been used in paediatric and adolescent rheumatology since the late 1960 s and is still being used in patients with inflammatory bowel disease, with systemic lupus erythematosus, dermatomyositis, polyarteriitis nodosa, and Behçet’s disease. In the treatment of juvenile idiopathic arthritis, azathioprine is still an option if methotrexate fails.
Schlüsselwörter
Azathioprin - Kinder - Jugendliche - Kollagenosen - Vaskulitis
Key words
azathioprine - children - adolescents - connective tissue diseases - vasculitis
Literatur
- 1
Al Mazyad A S.
Polyarteritis nodosa in Arab children in Saudi Arabia.
Clin Rheumatol.
1999;
18
196-200
Reference Ris Wihthout Link
- 2
Barnes B H, Borowitz S M, Saulsbury F T. et al .
Discordant erythrocyte sedimentation rate and C-reactive protein in children with
inflammatory bowel disease taking azathioprine or 6-mercaptopurine.
J Pediatr Gastroenterol Nutr.
2004;
38
509-512
Reference Ris Wihthout Link
- 3
Chowdhary V, Wakhlu A, Agarwal A. et al .
Outcome in juvenile dermatomyositis.
Indian Pediatr.
2002;
39
931-935
Reference Ris Wihthout Link
- 4
Dale I.
The treatment of juvenile rheumatoid arthritis with azathioprine.
Scand J Rheumatol.
1972;
1
125-127
Reference Ris Wihthout Link
- 5
Foster B J, Bernard C, Drummond K N. et al .
Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and
azathioprine: a clinical and histopathologic study.
J Pediatr.
2000;
136
370-375
Reference Ris Wihthout Link
- 6
Hagelberg S, Lee Y, Bargman J. et al .
Longterm followup of childhood lupus nephritis.
J Rheumatol.
2002;
29
2635-2642
Reference Ris Wihthout Link
- 7
Hamuryudan V, Ozyazgan Y, Hizli N. et al .
Azathioprine in Behcet’s syndrome: effects on long-term prognosis.
Arthritis Rheum.
1997;
40
769-774
Reference Ris Wihthout Link
- 8
Jacobs J C.
Methotrexate and azathioprine treatment of childhood dermatomyositis.
Pediatrics.
1977;
59
212-218
Reference Ris Wihthout Link
- 9
Jacobs J C.
Treatment of dermatomyositis.
Arthritis Rheum.
1977;
20 (Suppl)
338-341
Reference Ris Wihthout Link
- 10
Kader H A, Mascarenhas M R, Piccoli D A. et al .
Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with
severe ulcerative colitis.
J Pediatr Gastroenterol Nutr.
1999;
28
54-58
Reference Ris Wihthout Link
- 11
Kirschner B S.
Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory
bowel disease.
Gastroenterology.
1998;
115
813-821
Reference Ris Wihthout Link
- 12
Kölle Jr G.
Knochenmarksschädigung bei immunsuppressiver Therapie der juvenilen rheumatoiden Arthritis
und des Still-Syndroms mit Azathioprin.
Dtsch Med Wochenschr.
1969;
94
2268-2273
Reference Ris Wihthout Link
- 13
Kölle G.
Grundlagen und Praxis der immunsuppressiven Therapie bei rheumatoider Arthritis des
Kindes.
Monatsschr Kinderheilkd.
1972;
120
217-219
Reference Ris Wihthout Link
- 14
Kölle G, Stoeber E, Schöntag W.
Immunsuppressiva zur Basisbehandlung viszeraler Formen der kindlichen rheumatoiden
Arthritis.
Med Klinik.
1972;
67
603-607
Reference Ris Wihthout Link
- 15
Kvien T K, Hoyeraal H M, Sandstad B.
Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single
center double blind comparative study.
J Rheumatol.
1986;
13
118-123
Reference Ris Wihthout Link
- 16 Laxer R M. Pharmacology and Drug Therapy. Cassidy JT, Petty RE, Laxer RM, Lindsley CB Textbook of Pediatric Rheuamtology Philadelphia; Elesevier Saunders 2005: 76-141
Reference Ris Wihthout Link
- 17
Leipold G, Schütz E, Haas J P. et al .
Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of
the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated
spondylarthritis.
Arthritis Rheum.
1997;
40
1896-1898
Reference Ris Wihthout Link
- 18
Lin Y T, Yang Y H, Tsai M J. et al .
Long-term effects of azathioprine therapy for juvenile rheumatoid arthritis.
J Formos Med Assoc.
2000;
99
330-335
Reference Ris Wihthout Link
- 19
Lorenz K.
Immuno-deppressive Therapie bei Rheumatoid-Arthritis im Kindesalter.
Arch Kinderheilkd.
1966;
175
8-14
Reference Ris Wihthout Link
- 20
Markowitz J, Grancher K, Mandel F. et al .
Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey
of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee
on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
Am J Gastroenterol.
1993;
88
44-48
Reference Ris Wihthout Link
- 21
Miller L C, Michael A F, Kim Y.
Childhood Dermatomyositis Clinical course and long-term follow-up.
Clin Pediatr.
1987;
26
561-566
Reference Ris Wihthout Link
- 22
Ng Y T, Ouvrier R A, Wu T.
Drug therapy in juvenile dermatomyositis: follow-up study.
J Child Neurol.
1998;
13
109-112
Reference Ris Wihthout Link
- 23
Ramakrishna J, Langhans N, Calenda K. et al .
Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory
bowel disease.
J Pediatr Gastroenterol Nutr.
1996;
22
296-302
Reference Ris Wihthout Link
- 24
Rider L G, Miller F W.
Classification and treatment of the juvenile idiopathic inflammatory myopathies.
Rheum Dis Clin North Am.
1997;
23
619-655
Reference Ris Wihthout Link
- 25
Saenz A, Ausejo M, Shea B. et al .
Pharmacotherapy for Behcet’s syndrome.
Cochrane Database Syst Rev.
2000;
2
CD001084
Reference Ris Wihthout Link
- 26
Savolainen H A, Kautiainen H, Isomaki H. et al .
Azathioprine in patients with juvenile chronic arthritis: a longterm followup study.
J Rheumatol.
1997;
24
2444-2450
Reference Ris Wihthout Link
- 27
Shekelle P G, Woolf S H, Eccles M. et al .
Clinical guidelines: developing guidelines.
BMJ.
1999;
318
593-596
Reference Ris Wihthout Link
- 28
Singh S, Devidayal N N, Kumar L. et al .
Severe Henoch-Schonlein nephritis: resolution with azathioprine and steroids.
Rheumatol Int.
2002;
22
133-137
Reference Ris Wihthout Link
- 29
Stoeber E, Kölle G, Graner H P.
Immunsuppressive Therapie bei Kindern. Erste Erfahrungen mit Azathioprin (Imuran)
bei Still-Syndrom und rheumatoider Arthritis.
Munch Med Wochenschr.
1967;
109
1892-1899
Reference Ris Wihthout Link
- 30
Verhave M, Winter H S, Grand R J.
Azathioprine in the treatment of children with inflammatory bowel disease.
J Pediatr.
1990;
117
809-814
Reference Ris Wihthout Link
- 31
Weller F, Huppertz H I.
Die Behandlung des kindlichen Rheumas: Pharmakotherapie.
Z Rheumatol.
2005;
64
308-316
Reference Ris Wihthout Link
- 32
Yazici H, Pazarli H, Barnes C G. et al .
A controlled trial of azathioprine in Behcet’s syndrome.
N Engl J Med.
1990;
322
281-285
Reference Ris Wihthout Link
Dr. Hartmut Michels
Deutsches Zentrum für Kinder- und Jugendrheumatologie
Gehfeldstraße 24
82467 Garmisch-Partenkirchen
Phone: ++ 49/88 21/70 11 18
Fax: ++ 49/88 21/7 01-2 01
Email: michels.hartmut@rummelsberger.net